OSRHW
OSR Health, Inc.
Price Chart
Latest Quote
$0.05
-0.00 (-0.38%)
Current Price
| Previous Close | $0.05 |
| Open | $0.04 |
| Day High | $0.06 |
| Day Low | $0.05 |
| Volume | 3,249 |
Stock Information
| Total Debt | $4.95M |
| Cash Equivalents | $1.57M |
| Revenue | $2.63M |
| Net Income | $-9.55M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $2.63M |
| Income | $-9.55M |
| Book/sh | $3.12 |
| Employees | 22 |
Financial Ratios
| Quick Ratio | 0.10 |
| Current Ratio | 0.16 |
| Debt/Eq | 3.89 |
Returns & Margins
| ROA | -6.88% |
| ROE | -14.74% |
| Gross Margin | 20.85% |
| Operating Margin | -757.59% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.02 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| RSI | nan |
| ATR | nan |
| Shares Float | 14.65M |
| Volatility | 0.61 |
| Rel Volume | 20.00 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| YTD | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $nan | 3,249 |
| 2026-06-18 | $0.06 | 0 |
| 2026-06-17 | $0.06 | 0 |
| 2026-06-16 | $0.06 | 0 |
| 2026-06-15 | $0.06 | 0 |
| 2026-06-12 | $0.06 | 0 |
| 2026-06-11 | $0.06 | 0 |
| 2026-06-10 | $0.06 | 0 |
| 2026-06-09 | $0.06 | 0 |
| 2026-06-08 | $0.06 | 0 |
| 2026-06-05 | $0.06 | 0 |
| 2026-06-04 | $0.06 | 0 |
| 2026-06-03 | $0.06 | 0 |
| 2026-06-02 | $0.06 | 0 |
| 2026-06-01 | $0.06 | 0 |
| 2026-05-29 | $0.06 | 0 |
| 2026-05-28 | $0.06 | 0 |
| 2026-05-27 | $0.06 | 0 |
| 2026-05-26 | $0.06 | 0 |
About OSR Health, Inc.
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.
đ° Latest News
BC-Most Active Stocks
Associated Press Finance âĸ 2025-08-25T14:30:16ZOSR Holdings Second Quarter 2025 Earnings: EPS: US$0.02 (vs US$1.83 loss in 2Q 2024)
Simply Wall St. âĸ 2025-08-20T18:56:17Z
OSR Holdings to acquire South Koreaâs medical device company Woori IO
Medical Device Network âĸ 2025-07-28T09:49:31Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,312,900 | $2,720,356 | $2,516,772 | $0 |
| Cost Of Revenue | $2,312,900 | $2,719,067 | $2,534,487 | $0 |
| Total Revenue | $2,905,805 | $3,530,303 | $0 | $0 |
| Operating Revenue | $2,905,805 | $3,530,303 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $506,196 | $51,335 | $0 | $14,225 |
| Total Expenses | $21,241,808 | $15,222,500 | $1,830,700 | $621,316 |
| Rent Expense Supplemental | $97,527 | $113,472 | $22,985 | $329 |
| Other Income Expense | $-10,110,045 | $-170,441 | $-406,956 | $1,698,552 |
| Other Non Operating Income Expenses | $-10,110,045 | $-170,441 | $6,581 | $5,189 |
| Net Non Operating Interest Income Expense | $-442,313 | $-30,041 | $2,775,291 | $-12,268 |
| Interest Expense Non Operating | $506,196 | $51,335 | $0 | $14,225 |
| Operating Expense | $18,928,908 | $12,503,433 | $1,830,700 | $621,316 |
| Other Operating Expenses | $36,757 | $33,780 | $22,740 | $4,470 |
| Selling And Marketing Expense | $0 | $2,775 | $6,926 | $0 |
| General And Administrative Expense | $9,190,846 | $2,533,276 | $1,830,700 | $584,717 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,010,899 | $-10,328,910 | $403,780 | $1,064,967 |
| Net Interest Income | $-442,313 | $-30,041 | $2,775,291 | $-12,268 |
| Interest Income | $63,883 | $21,294 | $2,775,291 | $1,956 |
| Normalized Income | $-18,010,899 | $-10,328,910 | $403,780 | $-628,396 |
| Net Income From Continuing And Discontinued Operation | $-18,010,899 | $-10,328,910 | $403,780 | $1,064,967 |
| Total Operating Income As Reported | $-18,336,003 | $-11,692,197 | $-1,830,700 | $-621,317 |
| Net Income Common Stockholders | $-18,010,899 | $-10,328,910 | $403,780 | $1,064,967 |
| Net Income | $-18,010,899 | $-10,328,910 | $403,780 | $1,064,967 |
| Net Income Including Noncontrolling Interests | $-27,058,541 | $-10,328,910 | $403,780 | $1,064,967 |
| Net Income Continuous Operations | $-27,058,541 | $-10,328,910 | $403,780 | $1,064,967 |
| Pretax Income | $-28,888,361 | $-11,892,678 | $944,591 | $1,064,967 |
| Interest Income Non Operating | $63,883 | $21,294 | $2,775,291 | $1,956 |
| Operating Income | $-18,336,003 | $-11,692,197 | $-1,830,700 | $-621,316 |
| Depreciation Amortization Depletion Income Statement | $9,306,107 | $9,691,263 | $9,696,886 | $23,247 |
| Depreciation And Amortization In Income Statement | $9,306,107 | $9,691,263 | $9,696,886 | $23,247 |
| Amortization Of Intangibles Income Statement | $9,298,838 | $9,630,728 | $9,552,533 | $0 |
| Depreciation Income Statement | $7,269 | $60,535 | $144,353 | $23,247 |
| Gross Profit | $592,905 | $811,236 | $921,415 | $0 |
| Special Income Charges | - | - | $-311,165 | $1,748,689 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-19,076,058 | $-2,150,080 | $944,591 | $-590,925 |
| Reconciled Depreciation | $9,306,107 | $9,689,974 | $9,714,601 | $23,247 |
| EBITDA (Bullshit earnings) | $-19,076,058 | $-2,150,080 | $944,591 | $1,102,439 |
| EBIT | $-28,382,165 | $-11,841,343 | $944,591 | $1,079,192 |
| Diluted NI Availto Com Stockholders | $-18,010,899 | $-10,328,910 | $403,780 | $1,064,967 |
| Minority Interests | $9,047,642 | $0 | $0 | $0 |
| Tax Provision | $-1,829,820 | $-1,563,768 | $540,811 | $0 |
| Other Taxes | $34,495 | $23,478 | $21,527 | $8,882 |
| Provision For Doubtful Accounts | $42,257 | $57,706 | $35,302 | $0 |
| Amortization | $9,298,838 | $9,630,728 | $9,552,533 | $0 |
| Research And Development | $318,446 | $161,155 | $251,103 | $0 |
| Selling General And Administration | $9,190,846 | $2,536,051 | $1,830,700 | $584,717 |
| Other Gand A | $7,104,997 | $1,312,020 | $1,830,700 | $182,040 |
| Insurance And Claims | $16,962 | $13,170 | $20,856 | $1,080 |
| Rent And Landing Fees | $97,527 | $113,472 | $22,985 | $329 |
| Salaries And Wages | $1,971,360 | $1,094,614 | $1,039,390 | $401,268 |
| Total Unusual Items | - | - | $-413,537 | $1,693,364 |
| Total Unusual Items Excluding Goodwill | - | - | $-413,537 | $1,693,364 |
| Gain On Sale Of Ppe | - | - | $1,057 | $1,826,083 |
| Write Off | - | - | $0 | $77,395 |
| Impairment Of Capital Assets | - | - | $312,223 | $0 |
| Gain On Sale Of Security | - | - | $-102,372 | $-55,325 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-89,776,825 | $-29,202,702 | $32,519,461 | $-16,620,982 |
| Total Assets | $171,238,248 | $175,239,579 | $36,627,733 | $120,757,699 |
| Total Non Current Assets | $168,421,427 | $172,913,089 | $36,605,106 | $116,340,137 |
| Non Current Deferred Assets | $200,515 | $92,101 | $107,387,428 | $25,443 |
| Non Current Deferred Taxes Assets | $200,515 | $92,101 | $107,387,428 | $25,443 |
| Non Current Note Receivables | $555,190 | $306,494 | $440,421,683 | $218,503 |
| Investmentin Financial Assets | $1,115 | $1,088 | $7,947,500 | $5,287 |
| Goodwill And Other Intangible Assets | $167,412,440 | $172,410,918 | $278,365,579,988 | $115,719,302 |
| Other Intangible Assets | $142,462,634 | $148,056,852 | $230,848,992,354 | $103,588,368 |
| Current Assets | $2,816,821 | $2,326,490 | $22,627 | $4,417,562 |
| Other Current Assets | $-1 | $1 | $7,208 | - |
| Prepaid Assets | $321,052 | $129,015 | $160,277,726 | $16,320 |
| Inventory | $196,432 | $922,107 | $1,802,614,853 | $1,078,872 |
| Receivables | $599,065 | $933,824 | $0 | $505,966 |
| Other Receivables | $72,792 | $29,368 | $68,140,332 | $122,064 |
| Loans Receivable | $206,969 | $0 | $0 | - |
| Accounts Receivable | $319,304 | $904,456 | $1,475,402,380 | $372,397 |
| Allowance For Doubtful Accounts Receivable | $-62,370 | $-67,580 | $-45,492,513 | $0 |
| Gross Accounts Receivable | $381,674 | $972,036 | $1,520,894,893 | $372,397 |
| Cash Cash Equivalents And Short Term Investments | $1,700,273 | $341,543 | $15,419 | $2,816,405 |
| Cash And Cash Equivalents | $1,700,273 | $341,543 | $15,419 | $2,816,405 |
| Other Non Current Assets | - | $1 | $36,605,106 | $1 |
| Taxes Receivable | - | - | $6,705,149 | $11,504 |
| Debt | ||||
| Net Debt | $2,643,002 | $1,955,868 | $263,457,542 | - |
| Total Debt | $4,402,787 | $2,375,524 | $1,167,486,724 | $1,560,731 |
| Long Term Debt And Capital Lease Obligation | $12,551 | $530,987 | $561,657,569 | $373,689 |
| Current Debt And Capital Lease Obligation | $4,390,236 | $1,844,537 | $605,829,155 | $1,187,042 |
| Current Debt | $4,343,275 | $1,799,796 | $500,000,000 | $1,137,544 |
| Other Current Borrowings | $2,323,471 | $1,799,796 | $500,000,000 | $913,260 |
| Long Term Debt | - | $497,615 | $460,000,000 | $126,692 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $44,200,845 | $32,031,363 | $4,108,272 | $21,659,379 |
| Total Non Current Liabilities Net Minority Interest | $27,035,553 | $28,568,151 | $2,070,000 | $15,798,656 |
| Other Non Current Liabilities | $1,697 | $1,656 | - | - |
| Non Current Deferred Liabilities | $27,021,305 | $28,035,508 | $2,070,000 | $15,424,968 |
| Non Current Deferred Taxes Liabilities | $27,021,305 | $28,035,508 | $43,328,007,126 | $15,424,968 |
| Current Liabilities | $17,165,292 | $3,463,212 | $2,038,272 | $5,860,723 |
| Other Current Liabilities | $3,501,621 | $79,777 | $78,342,711 | $90,669 |
| Current Notes Payable | $2,019,804 | $0 | $0 | - |
| Payables And Accrued Expenses | $9,273,435 | $1,538,898 | $2,038,272 | $4,568,708 |
| Payables | $8,315,556 | $1,079,015 | $2,038,272 | $4,260,116 |
| Total Tax Payable | $485,452 | $255 | $884,519 | $4,273 |
| Income Tax Payable | $485,452 | $255 | $524,562 | $4,273 |
| Accounts Payable | $7,830,104 | $1,078,760 | $1,081,753 | $4,255,843 |
| Equity | ||||
| Common Stock Equity | $77,635,615 | $143,208,216 | $32,519,461 | $99,098,320 |
| Total Equity Gross Minority Interest | $127,037,403 | $143,208,216 | $32,519,461 | $99,098,320 |
| Stockholders Equity | $77,635,615 | $143,208,216 | $32,519,461 | $99,098,320 |
| Gains Losses Not Affecting Retained Earnings | $3,835,861 | $-225,386 | $168,940,276 | $0 |
| Other Equity Adjustments | $3,835,861 | $-225,386 | $168,940,276 | - |
| Retained Earnings | $-37,169,881 | $-19,173,063 | $-3,907,008 | $53,111 |
| Other | ||||
| Ordinary Shares Number | $26,597,769 | $19,276,978 | $19,276,978 | $19,276,978 |
| Share Issued | $26,597,769 | $19,276,978 | $19,276,978 | $19,276,978 |
| Tangible Book Value | $-89,776,825 | $-29,202,702 | $32,519,461 | $-16,620,982 |
| Invested Capital | $81,978,890 | $145,505,627 | $32,519,461 | $100,362,556 |
| Working Capital | $-14,348,471 | $-1,136,722 | $-2,015,645 | $-1,443,161 |
| Capital Lease Obligations | $59,512 | $78,113 | $207,486,724 | $296,495 |
| Total Capitalization | $77,635,615 | $143,705,831 | $32,519,461 | $99,225,011 |
| Minority Interest | $49,401,788 | $0 | $0 | $0 |
| Additional Paid In Capital | $110,966,975 | $162,606,449 | $0 | $94,449,980 |
| Capital Stock | $2,660 | $216 | $36,426,469 | $4,595,229 |
| Common Stock | $2,660 | $216 | $36,426,469 | $4,595,229 |
| Long Term Capital Lease Obligation | $12,551 | $33,372 | $101,657,569 | $246,997 |
| Current Capital Lease Obligation | $46,961 | $44,741 | $105,829,155 | $49,498 |
| Current Accrued Expenses | $957,879 | $459,883 | $558,554,905 | $308,591 |
| Investments And Advances | $1,115 | $1,088 | $7,947,500 | $5,287 |
| Available For Sale Securities | $1,115 | $1,088 | $7,947,500 | $5,287 |
| Goodwill | $24,949,806 | $24,354,066 | $47,516,587,634 | $12,130,934 |
| Net PPE | $252,167 | $102,487 | $235,437,968 | $371,600 |
| Accumulated Depreciation | $-291,099 | $-289,504 | $-662,543,658 | $-184,433 |
| Gross PPE | $543,266 | $391,991 | $897,981,626 | $556,034 |
| Construction In Progress | $22,612 | $21,669 | $34,917,468 | $52,830 |
| Other Properties | $83,667 | $101,171 | $33,350,272 | - |
| Machinery Furniture Equipment | $436,987 | $269,151 | $500,903,290 | $210,975 |
| Finished Goods | $196,432 | $922,107 | $1,802,614,853 | $1,078,872 |
| Other Short Term Investments | $0 | $0 | $0 | $0 |
| Preferred Stock | - | $0 | $0 | - |
| Dueto Related Parties Current | - | $72,000 | $72,000 | - |
| Duefrom Related Parties Current | - | $300,000 | $0 | - |
| Employee Benefits | - | - | $2,435,281 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | - | - | $2,435,281 | $0 |
| Line Of Credit | - | - | $0 | $224,284 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $27,797,324 | $14,304 |
| Buildings And Improvements | - | - | $328,810,596 | $292,228 |
| Properties | - | - | $0 | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,504,419 | $-1,849,474 | $-818,766 | $-593,703 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,328,034 | $-1,849,474 | $-818,766 | $-516,309 |
| Cash Flow From Continuing Operating Activities | $-4,328,034 | $-1,849,474 | $-818,766 | $-516,309 |
| Operating Gains Losses | $28,061 | $171,173 | $145,650 | $-1,817,178 |
| Investing Activities | ||||
| Capital Expenditure | $-176,385 | - | $-16,316 | $-77,395 |
| Investing Cash Flow | $-2,642,991 | $503,611 | $-33,829,815 | $-1,711,335 |
| Cash Flow From Continuing Investing Activities | $-2,642,991 | $503,611 | $-33,829,815 | $-1,711,335 |
| Net Other Investing Changes | $-3,259,296 | $497,390 | $-70,207,500 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,796,471 | $0 | $73,127,500 | $3,649,875 |
| Financing Cash Flow | $8,368,171 | $1,184,334 | $34,539,499 | $4,715,570 |
| Cash Flow From Continuing Financing Activities | $8,368,171 | $1,184,334 | $34,539,499 | $4,715,570 |
| Net Common Stock Issuance | $4,796,471 | $0 | $37,131,772 | $3,649,875 |
| Common Stock Issuance | $4,796,471 | $0 | $73,127,500 | $3,649,875 |
| Repurchase Of Capital Stock | - | $-36,232,029 | $-35,995,728 | - |
| Net Other Financing Charges | - | - | $-1,392,273 | - |
| Other | ||||
| Repayment Of Debt | $-1,666,856 | $-704,482 | $-1,200,000 | $-180,765 |
| Issuance Of Debt | $5,238,556 | $1,888,816 | $0 | $1,246,459 |
| Interest Paid Supplemental Data | $506,801 | $53,993 | - | - |
| Income Tax Paid Supplemental Data | $153,618 | $14,792 | $0 | - |
| End Cash Position | $1,700,273 | $341,543 | $15,419 | $2,816,405 |
| Beginning Cash Position | $341,543 | $540,207 | $124,501 | $349,266 |
| Effect Of Exchange Rate Changes | $-38,415 | $-37,135 | $-31,049 | $-20,787 |
| Changes In Cash | $1,397,145 | $-161,529 | $-109,082 | $2,487,926 |
| Net Issuance Payments Of Debt | $3,571,700 | $1,184,334 | $-1,200,000 | $1,065,694 |
| Net Short Term Debt Issuance | $2,980,389 | $996,912 | $-1,200,000 | $0 |
| Short Term Debt Payments | $-1,152,523 | $-655,232 | $-1,200,000 | $0 |
| Short Term Debt Issuance | $4,132,912 | $1,652,144 | $0 | $0 |
| Net Long Term Debt Issuance | $591,311 | $187,422 | $634,063 | $1,065,694 |
| Long Term Debt Payments | $-514,333 | $-49,250 | $-485,796 | $-180,765 |
| Long Term Debt Issuance | $1,105,644 | $236,672 | $1,119,859 | $1,246,459 |
| Net Investment Purchase And Sale | $-433,126 | $0 | $35,815,728 | $-3,415,212 |
| Purchase Of Investment | $-433,126 | $0 | $-180,000 | $-3,415,212 |
| Net Business Purchase And Sale | $1,224,794 | $0 | $0 | $1,781,271 |
| Sale Of Business | $1,224,794 | $0 | $0 | $1,781,271 |
| Net Intangibles Purchase And Sale | $-176,385 | $0 | $-7,441 | $0 |
| Purchase Of Intangibles | $-176,385 | $0 | $-7,441 | $0 |
| Net PPE Purchase And Sale | $1,022 | $6,221 | $-5,498 | $-77,395 |
| Sale Of PPE | $1,022 | $6,221 | $3,376 | $0 |
| Change In Working Capital | $1,705,458 | $-43,027 | $1,552,745 | $134,168 |
| Change In Other Current Liabilities | $-99,685 | $-65,519 | $-27,012 | $39,754 |
| Change In Other Current Assets | $350,645 | $-15,465 | $-52,682 | $-5,528 |
| Change In Payables And Accrued Expense | $120,031 | $-355,432 | $1,559,953 | $95,814 |
| Change In Accrued Expense | $476,645 | $3,392 | - | - |
| Change In Payable | $-356,614 | $-358,824 | $1,559,953 | $95,814 |
| Change In Account Payable | $-510,232 | $-344,032 | $1,035,391 | - |
| Change In Tax Payable | $153,618 | $-14,792 | $524,562 | - |
| Change In Income Tax Payable | $153,618 | $-14,792 | $524,562 | - |
| Change In Inventory | $763,734 | $305,604 | $-331,763 | $0 |
| Change In Receivables | $570,733 | $87,785 | $-745,195 | $4,127 |
| Other Non Cash Items | $12,050,955 | $154,387 | $-2,775,291 | $11,924 |
| Unrealized Gain Loss On Investment Securities | $1,436,321 | $0 | - | - |
| Asset Impairment Charge | $33,425 | $70,697 | $312,223 | $77,395 |
| Deferred Tax | $-1,829,820 | $-1,563,768 | $2,540 | $-145,165 |
| Deferred Income Tax | $-1,829,820 | $-1,563,768 | $2,540 | $-145,165 |
| Depreciation Amortization Depletion | $9,306,107 | $9,689,974 | $9,714,601 | $23,247 |
| Depreciation And Amortization | $9,306,107 | $9,689,974 | $9,714,601 | $23,247 |
| Amortization Cash Flow | $9,298,838 | $9,684,074 | $9,637,526 | $0 |
| Amortization Of Intangibles | $9,298,838 | $9,684,074 | $9,637,526 | $0 |
| Depreciation | $7,269 | $5,900 | $77,075 | $23,247 |
| Net Foreign Currency Exchange Gain Loss | $28,061 | $169,014 | $75,526 | $8,561 |
| Gain Loss On Sale Of PPE | $0 | $2,159 | $-1,057 | $0 |
| Net Income From Continuing Operations | $-27,058,541 | $-10,328,910 | $403,780 | $1,064,781 |
| Common Stock Payments | - | $-36,232,029 | $-35,995,728 | - |
| Interest Received Cfi | - | $455,662 | $561,957 | - |
| Sale Of Investment | - | $36,232,029 | $35,995,728 | - |
| Change In Prepaid Assets | - | $-82,055 | $-7,208 | - |
| Purchase Of PPE | - | - | $-8,874 | $-77,395 |
| Taxes Refund Paid | - | - | $-13,927 | $145,192 |
| Interest Received Cfo | - | - | $33,625 | $626 |
| Interest Paid Cfo | - | - | $-48,895 | $-11,297 |
| Provisionand Write Offof Assets | - | - | $25,555 | $0 |
| Pension And Employee Benefit Expense | - | - | $71,182 | $0 |
Fetched: 2026-06-19